Team

Business Development

Ingrid Stuiver, Ph.D.

Senior Director, Translational Research

Ingrid Stuiver is responsible for leading and executing the LJI translational strategies and pipeline by maintaining a deep engagement with the LJI discovery research teams and providing advice on potential preclinical and translational pathways with the final goal being commercial development. She ensures that the preclinical and development studies are rigorous and structured in preparation to secure solid intellectual property and for potential IND submissions. Ingrid also liaises between departments to ensure external fundraising exposure of those projects entering the commercial track.

Ingrid’s background encompasses a wide breadth of research and development as well as clinical experience in academic, commercial and healthcare settings. She has worked on numerous disease modalities including metabolic, inflammatory and infectious diseases and cancer. She is also versed in the translation of academic research to a for-profit entity, process development, clinical trial master files and GMP preparation and has directed and confirmed compliance of clinical CROs, core laboratories and GMP facilities and ensured that clinical research deliverables were received on time in the US and EU. In addition, Ingrid has worked with a number of for profit entities as VP of Clinical Operations and in that capacity overseen, developed and written the documentation needed for a number of successful FDA submissions. Finally, Ingrid has raised over $65 MM in grant funding and incentives for her research and other non- or for-profit entities.

Ingrid received her BA in Cell Biology and Biochemistry from the University of California, San Diego and her Ph.D. in Molecular and Cell Biology, Minor in Biochemistry from the University of Arizona, Tucson, AZ. She is also certified in Management, Biostatistics and ADMET.

Intellectual Property & Contracts

Margaret (Ng Thow) Hing, J.D.

Senior Director, Technology Development

Margaret (Ng Thow) Hing oversees all aspects of La Jolla Institute’s patent portfolio and technology agreements, and supports business development functions. In addition, she is active in drafting and prosecuting patent applications to issuance. Margaret works with scientific personnel on a daily basis to support their research activities by facilitating access to research tools and technologies, and ensuring intellectual property protection of research discoveries.

Prior to joining the Institute, Margaret was an attorney with Smart & Biggar, Fetherstonhaugh, a leading intellectual property and technology law firm. She advised clients on patent prosecution matters with a focus in the area of biotechnology. Margaret obtained a Master of Science in Molecular & Medical Genetics and J.D. from the University of Toronto, Canada.

Colleen Barefield, PhD

Technology Development Manager

Colleen provides scientific support for all technology development activities related to patent prosecution, commercial sponsored research agreements and alliance management and assists in licensing activities for the Institute’s technologies. Before joining La Jolla Institute, Colleen trained in diverse fields of biomedical research and therapeutic development, and her expertise extends to genetics and molecular biology in the fields of allergy, neurological disease, metabolic disease, and oncology. Her experience in industry encompasses high-throughput assay development and screening, and pre-clinical drug development.

After receiving her B.A. in Biology from Grinnell College, she spent two years in a pediatric epidemiology research laboratory at Washington University School of Medicine. Colleen obtained her Ph.D. from University of California San Diego and performed her doctoral research at the Salk Institute for Biological Studies where she studied chromosome end maintenance in the context of cancer and premature aging disorders. She then performed post-doctoral studies at the California Institute for Biomedical Research, a non-profit organization focused on translational research.

Stephen C. Pappas, J.D.

Intellectual Property Manager

As the Intellectual Property Manager at La Jolla Institute, Stephen Pappas is responsible for the daily management of LJI’s patent portfolio. He drafts and prosecutes patent applications, and processes new invention disclosures. Stephen is also responsible for drafting and negotiating agreements for commercial sponsored research projects and collaborations with other academic institutes.

Stephen is a registered patent agent and licensed attorney in the State of California. Before joining the Institute, Stephen was an associate at a San Francisco Bay Area intellectual property law firm. Stephen obtained a Bachelor of Science in microbiology from Purdue University and a J.D. from Santa Clara University School of Law.

Erin Randolph

Contract Specialist

Erin Randolph, as the Contract Specialist within Technology Development, is responsible for drafting and negotiating technology transfer agreements and manages the daily administrative operations of Technology Development. She has a background in contract review, communications, and operations.

Before joining LJI, Erin was an Executive Assistant at a major real estate firm and she previously handled marketing for the Bellagio (Las Vegas). Erin received her Bachelor of Business Administration in Management at Western Michigan University.